Related Experiment Video
Updated: May 1, 2026
Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head
Published on: September 27, 2024
Glucocorticoid induced osteoblast apoptosis by increasing E4BP4 expression via up-regulation of Bim
Abstract:
It is well known that glucocorticoid (GC)-induced bone loss is caused primarily by hypofunction and apoptosis of osteoblasts. However, the precise molecular events underlying the effect of GC on osteoblast apoptosis are not fully understood. Recent studies implicated an important role of E4BP4 in the regulation of osteoblast apoptosis and differentiation. Furthermore, E4BP4 is a GC-regulated gene required for GC-induced apoptosis in many cells. Therefore, we hypothesize that E4BP4 may be implicated in the process of GC-induced osteoblast apoptosis. Western blot, reverse-transcription-PCR, flow cytometry, and Hoechst 33258 staining were employed to investigate the role of E4BP4 in dexamethasone (DEX)-induced osteoblast apoptosis. We found that the expression of E4BP4 is significantly up-regulated in osteoblasts exposed to DEX. Furthermore, the depletion of E4BP4 significantly decreased DEX-induced osteoblast apoptosis. In addition, E4BP4 plays a crucial role in GC-evoked apoptosis of osteoblasts by enabling induction of Bim. On the basis of these results above, we can draw the conclusion that E4BP4 may contribute to the process of DEX-induced osteoblast apoptosis.
Insights
Glucocorticoids induce bone loss by promoting osteoblast apoptosis. This study reveals that E4BP4, a glucocorticoid-regulated gene, significantly contributes to this process by enabling the induction of Bim, a key apoptotic factor.
Area of Science:
- Molecular Biology
- Cell Biology
- Endocrinology
Background:
- Glucocorticoid (GC)-induced bone loss is a significant clinical issue.
- Osteoblast apoptosis is a primary mechanism driving GC-induced bone loss.
- The precise molecular pathways of GC-induced osteoblast apoptosis remain incompletely understood.
Purpose of the Study:
- To investigate the role of E4BP4 in glucocorticoid-induced osteoblast apoptosis.
- To elucidate the molecular mechanisms by which E4BP4 influences osteoblast survival under GC treatment.
Main Methods:
- Western blot analysis to assess protein expression.
- Reverse-transcription PCR (RT-PCR) for gene expression analysis.
- Flow cytometry and Hoechst 33258 staining to quantify apoptosis.
Main Results:
- E4BP4 expression was significantly upregulated in osteoblasts treated with dexamethasone (DEX).
- Depletion of E4BP4 markedly reduced DEX-induced osteoblast apoptosis.
- E4BP4 was found to be essential for GC-induced apoptosis by facilitating Bim induction.
Conclusions:
- E4BP4 plays a critical role in glucocorticoid-induced osteoblast apoptosis.
- E4BP4 contributes to DEX-induced osteoblast apoptosis, at least in part, by upregulating Bim.
- Targeting E4BP4 may offer a therapeutic strategy to mitigate GC-induced bone loss.
More Related Videos
13:54Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
Published on: October 21, 2012
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
Related Concept Videos
01:58Cell Specific Gene Expression
01:31The Intrinsic Apoptotic Pathway